BZYR 0.05 Burzynski Research Institute, Inc.
| Range: | 0.013-0.077 | Vol Avg: | 8626 | Last Div: | 0 | Changes: | -0.03 |
| Beta: | 0.97 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Thu Jan 02 1997 | Empoloyees: | |||
| CUSIP: | 123159105 | CIK: | 0000724445 | ISIN: | US1231591058 | Country: | US |
| CEO: | Dr. Stanislaw R. Burzynski M.D., Ph.D. | Website: | https://www.burzynskiclinic.com | ||||
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. The company is also involved in the production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow